PA8441401A1 - Procedimiento para piridinas sustituidas - Google Patents

Procedimiento para piridinas sustituidas

Info

Publication number
PA8441401A1
PA8441401A1 PA19978441401A PA8441401A PA8441401A1 PA 8441401 A1 PA8441401 A1 PA 8441401A1 PA 19978441401 A PA19978441401 A PA 19978441401A PA 8441401 A PA8441401 A PA 8441401A PA 8441401 A1 PA8441401 A1 PA 8441401A1
Authority
PA
Panama
Prior art keywords
procedure
amino
piridines
substituted
formula
Prior art date
Application number
PA19978441401A
Other languages
English (en)
Inventor
Robert Lee Dow
Keith Michael Devries
Stephen Wayne Wright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8441401A1 publication Critical patent/PA8441401A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A PROCEDIMIENTOS PARA PREPARAR COMPUESTOS DE LA FORMULA(I) Y A PROCEDIMIENTOS PARA PREPARAR CIERTOS INTERMEDIOS DE LA FORMULA EN LA QUE R1 ES NITRO, AMINO O AMINO PROTEGIDOS; R2 ES H, FLUORO, CLORO, CF3, NITRO, ALQUILO(C1-C4), ALCOXI(C1-C4), AMINO O AMINO PROTEGIDO; Y X1 ES OH O UN GRUPO SALIENTE ADECUADO, USADO EN ESTE PROCEDIMIENTO. LA INVENCION TAMBIEN SE REFIERE A NUEVOS COMPUESTOS DE FORMULA (II).
PA19978441401A 1996-11-14 1997-11-12 Procedimiento para piridinas sustituidas PA8441401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3088096P 1996-11-14 1996-11-14

Publications (1)

Publication Number Publication Date
PA8441401A1 true PA8441401A1 (es) 2000-05-24

Family

ID=21856496

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978441401A PA8441401A1 (es) 1996-11-14 1997-11-12 Procedimiento para piridinas sustituidas

Country Status (32)

Country Link
US (1) US6291489B1 (es)
EP (1) EP0938476B1 (es)
JP (1) JP3510635B2 (es)
KR (1) KR20000053314A (es)
CN (1) CN1237160A (es)
AP (1) AP805A (es)
AR (1) AR010584A1 (es)
AT (1) ATE319687T1 (es)
AU (1) AU4634697A (es)
BG (1) BG103393A (es)
BR (1) BR9712951A (es)
CA (1) CA2270386C (es)
CO (1) CO4930261A1 (es)
DE (1) DE69735433D1 (es)
EA (1) EA199900375A1 (es)
GT (1) GT199700118A (es)
HR (1) HRP970612A2 (es)
ID (1) ID18898A (es)
IL (1) IL129688A0 (es)
IS (1) IS5029A (es)
MA (1) MA24401A1 (es)
MY (1) MY132507A (es)
NO (1) NO992296L (es)
OA (1) OA11044A (es)
PA (1) PA8441401A1 (es)
PE (1) PE10299A1 (es)
TN (1) TNSN97172A1 (es)
TR (1) TR199901063T2 (es)
UY (1) UY24774A1 (es)
WO (1) WO1998021184A1 (es)
YU (1) YU22099A (es)
ZA (1) ZA9710186B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052892A2 (en) * 1998-04-08 1999-10-21 Novartis Ag Novel herbicides
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
US6515134B1 (en) * 1999-02-16 2003-02-04 Kaneka Corporation Substituted acetylpridine derivatives and process for the preparation of intermediates for optically active beta-3 agonist by the use of the same
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
DE60015036T2 (de) * 1999-07-23 2006-03-02 Pfizer Products Inc., Groton Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste
JPWO2003033468A1 (ja) * 2001-10-17 2005-02-03 株式会社カネカ （Ｓ）−α−ハロメチルピリジンメタノール誘導体の製造方法
WO2003072573A1 (en) * 2002-02-27 2003-09-04 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
CA2471646A1 (en) 2002-02-27 2003-09-04 Yong Tao Processes and intermediates useful in preparing .beta.3-adrenergic receptor agonists
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
KR100751163B1 (ko) 2003-05-09 2007-08-22 에프. 호프만-라 로슈 아게 알파-1 아드레날린 작용물질로서의 메틸 인돌 및 메틸피롤로피리딘
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
DE69404039T2 (de) * 1993-06-14 1997-10-16 Pfizer Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
IL113410A (en) * 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
EP0828712A1 (en) * 1995-05-10 1998-03-18 Pfizer Inc. Beta-adrenergic agonists
WO1996035671A1 (en) * 1995-05-10 1996-11-14 Pfizer Inc. β-ADRENERGIC AGONISTS

Also Published As

Publication number Publication date
NO992296D0 (no) 1999-05-12
BR9712951A (pt) 1999-12-07
CA2270386A1 (en) 1998-05-22
TR199901063T2 (xx) 1999-08-23
BG103393A (en) 2000-07-31
EA199900375A1 (ru) 1999-12-29
IS5029A (is) 1999-04-16
MY132507A (en) 2007-10-31
PE10299A1 (es) 1999-02-10
CN1237160A (zh) 1999-12-01
WO1998021184A1 (en) 1998-05-22
JP2000504347A (ja) 2000-04-11
EP0938476B1 (en) 2006-03-08
DE69735433D1 (de) 2006-05-04
YU22099A (sh) 2001-09-28
NO992296L (no) 1999-05-12
HRP970612A2 (en) 1998-08-31
KR20000053314A (ko) 2000-08-25
AP805A (en) 2000-01-28
EP0938476A1 (en) 1999-09-01
IL129688A0 (en) 2000-02-29
ATE319687T1 (de) 2006-03-15
AR010584A1 (es) 2000-06-28
OA11044A (en) 2002-02-20
CO4930261A1 (es) 2000-06-27
GT199700118A (es) 1999-05-05
ID18898A (id) 1998-05-20
ZA9710186B (en) 1999-05-12
AP9701147A0 (en) 1998-01-31
UY24774A1 (es) 1998-05-05
MA24401A1 (fr) 1998-07-01
CA2270386C (en) 2004-08-03
US6291489B1 (en) 2001-09-18
JP3510635B2 (ja) 2004-03-29
AU4634697A (en) 1998-06-03
TNSN97172A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
PA8441401A1 (es) Procedimiento para piridinas sustituidas
ES2142034T3 (es) Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PA8521701A1 (es) Derivados de pirazol
PT83713B (pt) Processo para a preparacao de derivados de 4-benzil-1-(2h)-ftalazinona e de composicoes farmaceuticas que os contem
CO4780028A1 (es) Procedimiento para la preparacion de sildenafil
BR9304185A (pt) Método para a utilização de um selante de fibrina, método para a preparação de ume composição que compreende monõmero de fibrina a partir de fibrinogénio, composição aquosa, composição, kit e suporte sólido
ES2058396T3 (es) N-isopropilanilidas de acido heteroariloxiacetico.
RS50437B (sr) Benzoilpirazoli i njihova primena u ulozi herbicida
ES2163512T3 (es) Nuevo compuesto, procedimiento para producirlo, y agente antitumoral.
ES2130312T3 (es) Nuevos derivados de tetrazina con actividad acaricida.
ES2143734T3 (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DK0634400T3 (da) Pyridincarboxyimidamidforbindelse og anvendelse deraf
YU19997A (sh) Analozi fluorovanog vitamina d3
ES2096344T3 (es) Sulfonilureas herbicidas, procedimiento para su obtencion y su empleo.
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PE20030346A1 (es) Proceso para la produccion de quinazolinas
GT199900113A (es) Inhibidores de las fkbp.
ES2076037T3 (es) Aminoesteres de los acidos 1,3,5-triacin-2,4,6-tris-alquilaminocarboxilicos, agentes biocidas que los contienen, asi como procedimiento para su fabricacion.
BR0211425A (pt) Método para a preparação de compostos, e, uso de uma composição
ES2114115T3 (es) Procedimiento y nuevos productos intermedios para la obtencion de triazolinonas.
SV1999000075A (es) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenemetil)-cefemos
PE36098A1 (es) Nuevas heteroariloxazolidinonas
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
BR9408078A (pt) Composto composição herbicida e processo para controlar vegetação indesejável